Corrigendum to "Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways" [Pharmacol. Rep. 70 (2018) 993-1000]
Pharmacol Rep. 2019 Dec;71(6):1227.
doi: 10.1016/j.pharep.2019.06.009.
Epub 2019 Oct 25.